1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Amryt Pharma Acquires Chiasma

M&A Deal Summary

Amryt Pharma Acquires Chiasma

On May 5, 2021, Amryt Pharma acquired life science company Chiasma

Acquisition Highlights
  • This is Amryt Pharma’s 4th transaction in the Life Science sector.
  • This is Amryt Pharma’s 2nd transaction in the United States.
  • This is Amryt Pharma’s 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2021-05-05
Target Chiasma
Sector Life Science
Buyer(s) Amryt Pharma
Deal Type Add-on Acquisition
Advisor(s) Torreya Partners (Financial)
Goodwin Procter (Legal)

Target

Chiasma

Needham, Massachusetts, United States
Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Chiasma was incorporated in 2001 and is headquartered in Needham, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Amryt Pharma

Dublin, Ireland
Category Company
Sector Life Science
Employees182
Revenue 182M GBP (2020)
DESCRIPTION

Amryt Pharma is a pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma is based in Dublin, Ireland.

DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 4 of 4
State: Massachusetts M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-21 Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States

Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.

Buy -
Mergr

Solution for

Product

Company

Legal